Search Results 681-690 of 17368 for maca benefits

1. Medical Research & Education - Mayo Clinic News Network

   Updated Testing Guidelines Make More Women Eligible for Herceptin, yet Benefit Uncertain featured image · Younger Onset Alzheimer's Disease Is Poorly Recognized ...

2. Medical Research & Education - Mayo Clinic News Network

   College senior trains in research to benefit Navajo community featured image. Research. College senior trains in research to benefit Navajo community. Mayo ...

3. RESET-SLE: A Phase 1/​2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

4. A Study of Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with MCL-1 Dependence ≥ 40% - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

5. Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

6. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

7. Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

8. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

9. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

10. Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

    ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...